Non-alcoholic fatty liver disease in diabetics - prevalence and predictive factors in a multiracial hospital clinic population in Malaysia-Reference-Cited by-同舟云学术

Non-alcoholic fatty liver disease in diabetics - prevalence and predictive factors in a multiracial hospital clinic population in Malaysia

Published:2013-07-22 Issue:8 Volume:28 Page:1375-1383
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:J Gastroenterol Hepatol

Author:

Chan Wah-Kheong¹,Tan Alexander Tong-Boon²,Vethakkan Shireene Ratna²,Tah Pei-Chien³,Vijayananthan Anushya⁴,Goh Khean-Lee¹

Affiliation:

1. Gastroenterology and Hepatology Unit; Gastrointestinal Endoscopy Unit; Department of Medicine; University of Malaya; Kuala Lumpur Malaysia

2. Endocrinology Unit; Department of Medicine; University of Malaya; Kuala Lumpur Malaysia

3. Department of Dietetics; University of Malaya Medical Centre; Kuala Lumpur Malaysia

4. Department of Bio-Medical Imaging; Faculty of Medicine; University of Malaya; Kuala Lumpur Malaysia

Funder

University of Malaya Research Grant

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jgh.12204/fullpdf

Reference29 articles.

1. Epidemiology of a fast emerging disease in the Asia-Pacific region-non-alcoholic fatty liver disease;Chan;Hepatol. Int.,2012

2. Prevalence and risk factors of non-alcoholic fatty liver disease in a multiracial suburban Asian population in Malaysia;Goh;Hepatol. Int.,2012

3. Increased prevalence of cardiovascular disease in Type 2 diabetic patients with non-alcoholic fatty liver disease;Targher;Diabet. Med.,2006

4. Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus;Leite;Liver Int.,2009

5. Prevalence of fatty liver disease among type 2 diabetes mellitus patients and its relation to insulin resistance;Merat;Middle East J. Dig. Dis.,2009

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of metabolic syndrome severity on racial and ethnic disparities in Metabolic Dysfunction-Associated Steatotic Liver Disease;PLOS ONE;2024-03-15

2. Is metabolic‐dysfunction‐associated fatty liver disease or advanced liver fibrosis associated with erythropoietin stimulating agent hypo‐responsiveness among patients with end‐stage kidney disease on haemodialysis?;Nephrology;2023-06-03

3. Glycemic and Extraglycemic Effects of Metformin in Patients with Diabetes;Metformin - A Prospective Alternative for the Treatment of Chronic Diseases;2023-04-05

4. Progress in Blood Glucose Monitoring in Patients with Hepatogenic Diabetes;J BIOL REG HOMEOS AG;2023

5. Comparison between obese and non-obese nonalcoholic fatty liver disease;Clinical and Molecular Hepatology;2023-02-28